ROS receptor tyrosine kinase: a new potential target for anticancer drugs
Author:
Publisher
Wiley
Subject
Drug Discovery,Pharmacology,Molecular Medicine
Reference150 articles.
1. The protein tyrosine kinase family of the human genome;Robinson;Oncogene,2000
2. Oncogenic kinase signaling;Blume-Jensen;Nature,2001
3. The molecular genetics of Philadelphia chromosome positive leukemias;Kurzrock;New Engl J Med,1988
4. Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: Clinical value of their detection by immunocytochemistry;Falini;Blood,2002
5. Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia;Druker;J Clin Invest,2000
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Therapeutic advances of targeting receptor tyrosine kinases in cancer;Signal Transduction and Targeted Therapy;2024-08-14
2. Revolutionizing non‐melanoma skin cancer treatment: Receptor tyrosine kinase inhibitors take the stage;Journal of Cosmetic Dermatology;2024-05-29
3. Novel therapeutic strategies for rare mutations in non-small cell lung cancer;Scientific Reports;2024-05-05
4. An analysis of the prognostic role of reactive oxygen species‐associated genes in breast cancer;Environmental Toxicology;2024-02-06
5. Unveiling Therapeutic Targets: Targeting Mitochondrial ROS for Anticancer Therapy;Cancer Drug Discovery and Development;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3